GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Construction In Progress

Cyfuse Biomedical KK (TSE:4892) Construction In Progress : 円53.01 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Construction In Progress?

Cyfuse Biomedical KK's quarterly construction in progress declined from Jun. 2023 (円54.23 Mil) to Sep. 2023 (円53.62 Mil) and declined from Sep. 2023 (円53.62 Mil) to Dec. 2023 (円53.01 Mil).

Cyfuse Biomedical KK's annual construction in progress declined from Dec. 2021 (円55.52 Mil) to Dec. 2022 (円55.45 Mil) and declined from Dec. 2022 (円55.45 Mil) to Dec. 2023 (円53.01 Mil).


Cyfuse Biomedical KK Construction In Progress Historical Data

The historical data trend for Cyfuse Biomedical KK's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Construction In Progress Chart

Cyfuse Biomedical KK Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Construction In Progress
5.83 55.52 55.45 53.01

Cyfuse Biomedical KK Quarterly Data
Dec20 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Construction In Progress Get a 7-Day Free Trial Premium Member Only 55.45 54.84 54.23 53.62 53.01

Cyfuse Biomedical KK Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Cyfuse Biomedical KK (TSE:4892) Business Description

Traded in Other Exchanges
N/A
Address
3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN
Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK (TSE:4892) Headlines

No Headlines